Effective inhibition of human cytomegalovirus gene expression by DNA-based external guide sequences

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 5, 2009, Pages 389-398

  Zeng, Zhifeng ^a   Li, Hongjian ^a   Li, Yueqing ^a   Cui, Yanwei ^a   Zhou, Qi ^a   Zou, Yi ^a   Yang, Guang ^a   Zhou, Tianhong ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Antivirus; DNA based miniEGSs; Gene silence; Human cytomegalovirus; RNase P

Indexed keywords

OLIGODEOXYRIBONUCLEOTIDE; RIBONUCLEASE P; VIRUS PROTEIN;

ARTICLE; CYTOMEGALOVIRUS; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVE SITE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CATALYTIC DOMAIN; CYTOMEGALOVIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE P; TRANSFECTION; VIRAL STRUCTURAL PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 66449095240     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp024     Document Type: Article

References (44)

1. Sun Y, Chen X and Xiao D. Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim Biophys Sin 2007, 39: 235-246. (Pubitemid 46625305)
2. Sun L, Cai L, Yu Y, Meng Q, Cheng X, Zhao Y and Sui G et al. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epiru- bicin. Acta Biochim Biophys Sin 2007, 39: 999-1007. (Pubitemid 350274290)
3. Stein CA and Cheng YC. Antisense oligonucleotides as therapeutic agents-is the bullet really magical. Science 1993, 261: 1004-1012. (Pubitemid 23300859)
4. Santoro SW and Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 1997, 94: 4262-4266. (Pubitemid 27194229)
5. Wong-Staal F, Poeschla EM and Looney DJ. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transuded with a ribozyme that cleaves HIV-1 RNA. Hum Gene Ther 1998, 9: 2407-2425. (Pubitemid 28523990)
6. Scherer LJ and Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol 2003, 21: 1457-1465. (Pubitemid 37522705)
7. Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G and Williams BR et al. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 1994, 265: 789-792. (Pubitemid 2115113)
8. Yuan Y and Altman S. Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease P. Science 1994, 263: 1269-1273. (Pubitemid 24107545)
9. Kahle D, Wehmeyer U and Krupp G. Substrate recognition by RNase P and by the catalytic M1 RNA: identification of possible contact points in pre-tRNAs. EMBO J 1990, 9: 1929-1937. (Pubitemid 20170027)
10. Thurlow DL, Shilowski D and Marsh TL. Nucleotides in precursor tRNA that are required intact for catalysis by RNase P RNAs. Nucleic Acids Res 1991, 19: 885-890. (Pubitemid 21913166)
11. Conrad F, Hanne A, Gaur RK and Krupp G. Enzymatic synthesis of 2′ modified nucleic acids: identification of important phosphates and ribose moieties in RNase P substrates. Nucleic Acids Res 1995, 23: 1845-1853.
12. Pan T, Loria A and Zhong K. Probing of tertiary interactions in RNA: 2′-hydroxyl-base contacts between the RNase P RNA and pre-tRNA. Proc Natl Acad Sci USA 1995, 92: 12510-12514. (Pubitemid 26014099)
13. Loria A and Pan T. Recognition of the T stem-loop of a pre-tRNA substrate by the ribozyme from Bacillus subtilis ribonuclease P. Biochemistry 1997, 6317-6325. (Pubitemid 27231387)
14. Hardt WD, Schlegl J, Erdmann VA and Hartmann RK. Role of the D arm and anticodon arm in tRNA recognition by eubacterial and eukary- otic RNase P enzyme. Biochemistry 1993, 32: 13046-13053. (Pubitemid 24005911)
15. Yuan Y and Altman S. Substrate recognition by human RNase P: identification of small model substrates for the enzyme. EMBO J 1995, 14: 159-168.
16. Carrara G, Calandra P, Fruscolini P and Tocchini-Valentini GP. Two helices plus a linker: small model substrate for eukaryotic RNase P. Proc Natl Acad Sci USA 1995, 92: 2627-2631.
17. Forster AC and Altman S. External guide sequences for an RNA enzyme. Science 1990, 249: 783-786. (Pubitemid 20259115)
18. Yuan Y, Hwang ES and Altman S. Targeted cleavage of mRNA by human RNase P. Proc Natl Acad Sci USA 1992, 89: 8006-8010.
19. Zhu J, Trang P, Kim K, Zhou T, Deng H and Liu F. Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpes virus by human RNase P. Proc Natl Acad Sci USA 2004, 101:9073-9078. (Pubitemid 38781613)
20. Li H, Trang P, Kim K, Zhou T, Umamoto S and Liu F. Effective inhibition of human cytomegalovirus gene expression and growth by intracellular expression of external guide sequence RNA. RNA 2006, 12: 63-72. (Pubitemid 43037454)
21. Zhang WJ, Li HJ, Li YQ, He HK, Tang DS, Zhang X and Zhou TH. Construction of an effective M1GS ribozyme targeting HCMV UL97 mRNA segment in vitro. Yi Chuan Xue Bao 2005, 32: 1205-1212. (Pubitemid 41752353)
22. Su YZ, Li HJ, Li YQ, Chen HJ, Tang DS, Zhang X and Jiang H et al. In vitro construction of effective M1GS ribozymes targeting HCMV UL54 RNA segments. Acta Biochim Biophys Sin 2005, 37: 210-214. (Pubitemid 40720567)
23. Altman S. RNase P in research and therapy. Biotechnology (NY) 1995, 13: 327-329.
24. Krupp G. Antisense oligoribonucleotides and RNase P. A great potential. Biochimie 1993, 75: 135-138. (Pubitemid 23140163)
25. Hartmann RK, Krupp G and Hardt WD. Towards a new concept of gene inactivation: specific RNA cleavage by endogenous ribonuclease P. In: El-Gewely MR ed. Biotechnology Annual Review, vol 1. Amsterdam: Elsevier, 1995, 215-265.
26. Werner M, Rosa E, Nordstrom JL, Goldberg AR and George ST. Short oligonucleotides as external guide sequences for site-specific cleavage of RNA molecules with human RNase P. RNA 1998, 4: 847-855. (Pubitemid 28317832)
27. Guerrier-Takada C, Li Y and Altman S. Artificial regulation of gene expression in Escherichia coli by RNase P. Proc Natl Acad Sci USA 1995, 92: 11115-11119. (Pubitemid 3015331)
28. Kawa D, Wang J, Yuan Y and Liu F. Inhibition of viral gene expression by human ribonuclease P. RNA 1998, 4: 1397-1406. (Pubitemid 28503525)
29. Plehn-Dujowich D and Altman S. Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribo-nuclease P. Proc Natl Acad Sci USA 1998, 95: 7327-7332. (Pubitemid 28293251)
30. Ma M, Benimetskaya L, Lebedeva I, Dignam J, Takle G and Stein CA. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat Biotechnol 2000, 18: 58-61. (Pubitemid 30041173)
31. Ma MY, Jacob-Samuel B, Diagram JC, Pace U, Goldberg AR and George ST. Nuclease-resistant external guide sequence-induced cleavage of target RNA by human ribonuclease P. Antisense Nucleic Acid Drug Dev 1998, 8: 415-426. (Pubitemid 28510827)
32. Perreault JP and Altman S. Important 2′-hydroxyl groups in model substrates for M1 RNA, the catalytic RNA subunit of RNase P from Escherichia coli. J Mol Biol 1992, 226: 399-409.
33. Mocarski ES and Courcelle CT. Cytomegalovirus and their replication. In: Knipe DM and Howley PM eds. Fields Virology. Philadelphia, PA: Lippincott-William & Wilkins, 2001, 2629-2673.
34. He R, Ruan Q, Qi Y, Ma YP, Huang YJ, Sun ZR and Ji YH. Sequence variability of human cytomegalovirus UL143 in low-passage clinical isolates. Chin Med J (Engl) 2006, 119: 397-402. (Pubitemid 43796894)
35. Zhang C, Shen K, Jiang Z and He X. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus. Chin Med J (Engl) 2001, 114: 1309-1312. (Pubitemid 34041507)
36. Jiang H, Wen L and Ling X. Diagnostic value of human cytomegalo- virus late mRNA detection in active intrauterine infection. Chin Med J (Engl) 2002, 115: 1507-1509. (Pubitemid 35282911)
37. Zhou XM, Lin LS, Shi Y, Tian DA, Huang HJ, Zhou HJ and Jin YX. Establishment of a screening system for selection of siRNA target sites directed against hepatitis B virus surface gene. Acta Biochim Biophys Sin 2005, 37: 310-316. (Pubitemid 41169478)
38. Pass RF. Cytomegalovirus. In: Knipe DM and Howley PM eds. Fields Virology. Philadelphia, PA: Lippincott-William & Wilkins, 2001, 2675-2706.
39. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V and Zhu H et al. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA 2003, 100: 14223-14228.
40. Altman S and Kirsebom LA. Ribonuclease in the RNA world. In: Gesteland RF et al. eds. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999, 351-380.
41. Raj SM and Liu F. Engineering of RNase P ribozyme for gene targeting applications. Gene 2003, 313: 59-69. (Pubitemid 37338239)
42. Ma M, Benimetskaya L, Lebedeva I, Dignam J, Takle G and Stein CA. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat Biotechnol 2000, 18: 58-61. (Pubitemid 30041173)
43. Rudnick SI, Swaminathan J, Sumaroka M, Liebhaber S and Gewirtz AM. Effects of local mRNA structure on posttranscriptional gene silencing. Proc Natl Acad Sci USA 2008, 105: 13787-13792.
44. Reeves MB, MacAry PA, Lehner PJ, Sissons JGP and Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalo- virus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005, 102: 4140-4145. (Pubitemid 40388569)